Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Goldilocks fludarabine therapeutic drug monitoring in children and young adults undergoing CAR-T therapy for acute lymphoblastic leukaemia
ISRCTN10473740Phase 4Recruiting
- Sponsor
- Newcastle Hospitals NHS Foundation Trust
- Start
- Feb 2026
- Modality
- Small Molecules, Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules, DNA Intercalators/Alkylators → Nucleic Acid-Directed Small Molecules → Small Molecules
01
Overview
Phase 4, open-label, single-arm trial of fludarabine and cyclophosphamide in acute lymphoblastic leukemia (ALL), sponsored by Newcastle Hospitals NHS Foundation Trust. Primary endpoint: Feasibility of implementation. Started Feb 2026; status: recruiting.
02
Drugs
fludarabinecyclophosphamide
03
Conditions
acute lymphoblastic leukemia (ALL)
Beyond the preview
Go deeper on ISRCTN10473740.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ISRCTN10473740.